NANOINK IMAGING--MAKING DISEASE VISIBLE

NanoInk Imaging, a spin-out of Rutgers University, is developing an optical imaging technology based on targeted nanoprobes that emit short-wave infrared (SWIR) light.

These nanoprobes offer enhanced tissue transparency, deeper tissue illumination potential, and molecular targeting of cell surface markers. 

The first application is in pre-clinical drug discovery, where our nanoprobes provide more detailed images  of the tumor and the tumor micro-environment in small animal disease models.

The second application is in Cancer Surgery, where our nanoprobes will enable surgeons to visualize tumor margins in real-time and reduce the need for repeat surgeries.